Published in New England Journal of Medicine · View the paper (DOI)
Two NIH-funded studies influenced the WHO's revision of its guidelines for treating HIV-infected women and infants. The studies found that a single dose of nevirapine to prevent mother-to-child transmission can hamper the drug's effectiveness if used later as part of a treatment regimen. As a result, the new guidelines advise against u...
Coverage from 2 institutions